Novo Nordisk chair foresees pressure on pharmaceutical industry
Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Novo Nordisk's Chair of the Board Helge Lund predicts that Danish tax payers will, to a large extent, be paying the bills for the coronavirus crisis in this country, but that the pharmaceutical industry will also be put under pressure, according to Danish media Finans.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Eli Lilly surpasses Novo's golden diabetes drug
For subscribers
